FIRST AMENDMENT TO SUBORDINATED SECURED NOTE PURCHASE AGREEMENT
Exhibit 10.1
EXECUTION COPY
FIRST AMENDMENT TO SUBORDINATED SECURED NOTE PURCHASE AGREEMENT
THIS FIRST AMENDMENT TO SUBORDINATED SECURED NOTE PURCHASE AGREEMENT (the First Amendment) is made this 30th day of November, 2011 (the Effective Date), by and among HELICOS BIOSCIENCES CORPORATION, a Delaware corporation (the Company), and each of the purchasers named on the Schedule of Purchasers attached hereto as Schedule 1 (the Schedule of Purchasers) as a Purchaser (each individually a Purchaser, and collectively the Purchasers).
BACKGROUND:
WHEREAS, reference is made to a certain Subordinated Secured Note Purchase Agreement dated as of November 16, 2010 by and among the Company and the Purchasers (the Note Purchase Agreement). Capitalized terms used but not defined herein shall have the same meaning as in the Note Purchase Agreement.
WHEREAS, the Company continues to require additional funds in order to fund its operations;
WHEREAS, the Company desires to issue and sell the Notes to the Purchasers, and the Purchasers desire to purchase the Notes from the Company, as set forth herein and in the Notes; and
WHEREAS, the Company and the Purchasers now desire to amend the Note Purchase Agreement as set forth herein.
AGREEMENTS:
NOW, THEREFORE, in consideration of the mutual covenants and agreements herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Company and the Purchasers hereby agree and amend the Note Purchase Agreement as follows:
1. Additional Committed Loan Closings. Section 2.1(b)(ii) and (iv) of the Note Purchase Agreement is hereby amended and restated as follows:
(ii) Additional Committed Loan Closings. One or more additional Closings (each an Additional Committed Loan Closing and together, the Additional Committed Loan Closings) of the sale by the Company of Committed Notes and the purchase by the Purchasers of Committed Notes issued by the Company shall be held via the remote exchange of documents on such dates occurring on or before the earlier to occur of (i) December 31, 2012 and (ii) the occurrence of
any event described in Section 7.1(f) of this Agreement (such earlier date being referred to as the Commitment Termination Date) as the Company shall request in written notices (each, a Notice) (which shall indicate the aggregate principal amount of additional Notes the Company requests to issue at such Additional Committed Loan Closing) to be delivered to the Purchasers at least ten (10) days prior to the proposed date of each such Additional Committed Loan Closing; provided that (i) the Notes to be issued pursuant to Section 2.1(a)(i)(B) shall be Committed Notes (and their issuance shall reduce the remaining amount of the commitment to issue Committed Notes on a dollar for dollar basis), shall be in an aggregate original principal amount as requested by the Company in the Notice with respect to each such Additional Committed Loan Closing, and shall be issued no more frequently than once per calendar month or on such other dates as may be agreed between the Company and the Majority Purchasers), (ii) the aggregate amount of Notes purchased by any Purchaser shall not exceed $1,000,000.02 for the Committed Notes, (iii) no Committed Notes shall be issued at any Additional Committed Loan Closing unless the conditions to Additional Committed Loan Closings set forth on Schedule 2.1(b)(ii) attached hereto have been fulfilled (or waived by all the Purchasers).
(iv) Transactions at Each Closing. At each Closing, the Company shall issue and the Purchasers shall purchase, on a several and not joint basis, the amount of Notes as provided in Section 2.1 hereof (but in any event, at each Closing on the purchase and sale of a Committed Note, including at the Initial Loan Closing, the aggregate amount of Notes to be issued at such Closing shall not exceed the principal amount as requested by the Company in the Notice, and with respect to the purchase and sale of all Notes, the aggregate original principal amount shall not exceed $4,000,000). At each Closing, the Company shall issue to each Purchaser a Note representing the principal amount of the Note issued to such Purchaser at such Loan Closing.
2. Ratification. In all other respects the Note Purchase Agreement shall remain unmodified and shall continue in full force and effect, as amended hereby. The parties hereby ratify, confirm, and reaffirm all of the terms and conditions of the Note Purchase Agreement, as amended hereby.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
IN WITNESS WHEREOF, the parties have executed this Subordinated Secured Note Purchase Agreement as an instrument under seal as of the date first above written.
| COMPANY: | |
|
| |
|
| |
| HELICOS BIOSCIENCES CORPORATION | |
|
| |
|
| |
| By: | /s/ Jeffrey R. Moore |
|
| Name: Jeffrey R. Moore |
|
| Title: Senior Vice President and Chief Financial Officer |
|
| |
| Jurisdiction of Organization: Delaware | |
| Chief Executive Office: | |
| One Kendall Square | |
| Suite 7301 | |
| Cambridge, MA 02139 |
| PURCHASERS: | ||||
|
| ||||
|
| ||||
| APPLIED GENOMIC TECHNOLOGY CAPITAL FUND, L.P.; | ||||
| AGTC ADVISORS FUND, L.P. | ||||
|
| Each by AGTC Partners, L.P., its General Partner | |||
|
| By NewcoGen Group Inc. its General Partner | |||
|
|
| |||
|
|
| |||
|
| By: | /s/ Noubar Afeyan | ||
|
|
| Name: Noubar Afeyan | ||
|
|
| Title: President | ||
|
|
| |||
|
|
| |||
| Notice Address: | ||||
|
| ||||
| One Memorial Drive, Seventh Floor | ||||
| Cambridge, MA 02142 | ||||
| Attn: | ||||
|
| ||||
|
| ||||
| NEWCOGEN GROUP LLC; | ||||
| NEWCOGEN EQUITY INVESTORS LLC; | ||||
| NEWCOGEN-ELAN LLC; | ||||
| NEWCOGEN-PE LLC; | ||||
| NEWCOGEN-LONG REIGN HOLDING LLC; | ||||
| ST NEWCOGEN LLC | ||||
|
| ||||
| Each by its Manager NewcoGen Group Inc. | ||||
|
| ||||
| By: | /s/ Noubar Afeyan | |||
|
| Name: Noubar Afeyan | |||
|
| Title: President | |||
|
| ||||
|
| ||||
| Notice Address: | ||||
|
| ||||
| One Memorial Drive, Seventh Floor | ||||
| Cambridge, MA 02142 | ||||
| Attn: | ||||
|
| ||||
| PURCHASERS: | ||||
|
| ||||
| FLAGSHIP VENTURES FUND 2004, L.P. | ||||
|
| ||||
|
| By its General Partner | |||
|
| Flagship Ventures General Partner | |||
|
| LLC | |||
|
|
| |||
|
| By: : | /s/ Noubar Afeyan | ||
|
|
| Manager | ||
|
| ||||
|
| ||||
| Notice Address: | ||||
| One Memorial Drive, Seventh Floor | ||||
| Cambridge, MA 02142 | ||||
| Attn: | ||||
| PURCHASERS: | |
|
| |
| ATLAS VENTURE FUND VI, L.P. | |
| ATLAS VENTURE ENTREPRENEURS FUND VI, L.P. | |
| By: | Atlas Venture Associates VI, L.P. |
|
| Their General Partner |
| By: | Atlas Venture Associates VI, Inc. |
|
| Its General Partner |
|
|
|
| By: | /s/ Kristen Laguerre |
|
| Name: Kristen Laguerre |
|
| Title: Vice President |
|
| |
| Notice Address: | |
|
| |
| 25 First Street, Suite 303 | |
| Cambridge, MA 02141 | |
| Attention: General Counsel | |
|
| |
| ATLAS VENTURE FUND VI, GMBH & CO. KG | |
| By: | Atlas Venture Associates VI, L.P. |
|
| Its Managing Limited Partner |
| By: | Atlas Venture Associates VI, Inc. |
|
| Its General Partner |
|
|
|
| By: | /s/ Kristen Laguerre |
|
| Name: Kristen Laguerre |
|
| Title: Vice President |
|
| |
| Notice Address: | |
|
| |
| 25 First Street, Suite 303 | |
| Cambridge, MA 02141 | |
| Attention: General Counsel | |
|
| |
| PURCHASERS: | |
|
| |
| ATLAS VENTURE FUND V, L.P. | |
| ATLAS VENTURE ENTREPRENEURS FUND V, L.P. | |
| By: | Atlas Venture Associates V, L.P. |
|
| Their General Partner |
| By: | Atlas Venture Associates V, Inc. |
|
| Its General Partner |
|
| |
| By: | /s/ Kristen Laguerre |
|
| Name: Kristen Laguerre |
|
| Title: Vice President |
|
| |
| Notice Address: | |
|
| |
| 25 First Street, Suite 303 | |
| Cambridge, MA 02141 | |
|
| |
| Attention: General Counsel |